Embecta Corp. (NASDAQ:EMBC) posted on Friday the second-quarter 2025 adjusted earnings of 70 cents per share, up from 67 ...

Reduced debt during the fiscal year 2025 second quarter by paying down approximately $27.4 million of outstanding principal ...

Embecta now expects revenues between $1.073 billion and $1.09 billion. This would mark a sales dip of between 4.4% and 2.9% ...

Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment ...

NEW YORK - Embecta Corp. (NASDAQ: EMBC) reported better-than-expected second quarter results on Friday, as the diabetes care company beat analyst estimates for both earnings and r ...

Q2 2025 Earnings Conference Call May 9, 2025 8:00 AM ETCompany ParticipantsDev Kurdikar - President & CEOJake Elguicze ...

Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...

In the first quarter of 2025, net revenue increased organically with continued good profitability, which shows stable demand in medical technology and laboratory solutions. Cash flow from operating ac ...

Gain insights, see trends and get real-time updates when you securely link or manually add your brokerage accounts.